| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.19B | +11.1% |
| Gross profit | ¥0.09B | — |
| Operating income | ¥0.04B | — |
| Net income | ¥0.03B | +4.7% |
| Gross margin | 45.6% | Net margin 16.8% |
| Revenue Q/Q | -29.7% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.10B | 54.4% |
| R&D | ¥0.02B | 9.6% |
| SG&A | ¥0.03B | 15.5% |
| Tax & other | ¥0.01B | 3.9% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
金凯生科 ・ 固高科技 ・ 德福科技 ・ 智信精密 ・ 尚水智能 ・ 港通医疗 ・ 中远通 ・ 陕西华达 ・ 长华化学 ・ 舜禹股份 ・ 万邦医药 ・ 上大股份
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies